3 documents found, page 1 of 1
Predictors of ACEI/ARB therapy in patients with hypertrophic cardiomyopathy : r...
Martins, E.; Lebreiro, A.; Sousa, C.; Leite, S.; Sousa, A.; Belo, A.; Brito, Dulce; Cardim, N.Introduction: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are not considered disease-modifying drugs in hypertrophic cardiomyopathy (HCM) and their use is usually dependent on other clinical indications. Few data exist about the use of ACEI/ARB in HC in the real world, particularly in patients with intraventricular obstruction. Objective: In this study, we sought t...
Diagnosis and treatment of acute myocarditis in Portugal. Data from the nationa...
Brito, D.; Cardim, N.; Lopes, L. Rocha; Freitas, A.; Lacerda, A. Pais de; Menezes, M.; Belo, A.; Martins, E.; Peres, M.; Goncalves, L.; Mimoso, J.Introduction: The diagnosis of acute myocarditis (aMyo) needs a high level of suspicion. Cardiac magnetic resonance (CMR) may contribute to the diagnosis; but endomyocardial biopsy (EMB) is considered the gold standard, although used infrequently worldwide. Short-term course, albeit unpredictable is usually benign and treatment is mainly supportive. Objectives: To assess the usual care attitudes regarding hospi...
Updated standards and processes for accreditation of echocardiographic laborato...
Popescu, B. A.; Stefanidis, A.; Nihoyannopoulos, P.; Fox, K. F.; Ray, S.; Cardim, N.; Rigo, F.; Badano, L. P.; Fraser, A. G.; Pinto, Fausto J.Standards for echocardiographic laboratories were proposed by the European Association of Echocardiography (now the European Association of Cardiovascular Imaging) 7 years ago in order to raise standards of practice and improve the quality of care. Criteria and requirements were published at that time for transthoracic, transoesophageal, and stress echocardiography. This paper reassesses and updates the quality...